GE HealthCare Events Center

Biomarker guided therapy — Advancing precision oncology

Radiation oncology is entering a new era in which treatment decisions are no longer based solely on anatomical imaging but are increasingly guided by the biological characteristics of individual tumors. Biomarkers have the potential to transform radiation therapy into a truly personalized modality, enabling not only improved patient selection but also optimization of treatment approach, sequencing, and timing.

This symposium will examine emerging biomarker-driven strategies that enable more adaptive and response-guided radiation therapy. Particular focus will be placed on the integration of functional imaging and radiomics into treatment planning and delivery.

Speaker(s):

Host & Moderator: Ilya Gipp, M.D., PhD., Chief Medical Officer, Oncology, GE HealthCare

ACKNOWLEDGEMENTS

GE HealthCare Events Center

Product availability

Not all products and solutions, shown on the GE HealthCare Events Center, may be available in your country. Please contact a GE HealthCare representative to confirm availability.

Information We Collect

We want to be transparent about the data we and our partners collect and how we use it, so you can best exercise control over your personal data. For more information, please see our Privacy Policy.

We use the following partners to better improve your overall web browsing experience. They use cookies and other mechanisms to connect you with your social networks and tailor advertising to better match your interests. You can elect to opt-out of this information collection by unticking the boxes below.

Biomarker-guided therapy: Advancing precision oncology